This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents. Top assignees: Mutual Pharmaceutical Company, Inc., Monsanto Company, Mutual Pharmacuetical Company, Inc.. Active years: 1997-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kirkwood, MO (US) (1997 - 2002)
- Morrisville, PA (US) (2009 - 2014)
Company Filing History:
5 out of 29 
3 out of 3,289 
1 out of 1 Years Active: 1997-2014
Title: Innovations by Kristin Anne Arnold: A Pioneer in Controlled-Release Formulations
Introduction
Kristin Anne Arnold is an accomplished inventor based in Morrisville, Pennsylvania, known for her significant contributions to the field of pharmaceutical science. With six patents to her name, she has developed innovative solutions that enhance the delivery and efficacy of therapeutic agents.
Latest Patents
Among her latest innovations is a patent for controlled-release formulations, which encompasses a matrix that contains a pharmaceutically effective amount of an active agent or acceptable derivatives. The invention highlights a unique ionic non-gelling matrix polymer that remains insoluble at a specific pH level, ultimately controlling the release of the active agent. This controlled-release composition notably eliminates the need for gelling or swellable excipients, representing a groundbreaking approach in pharmaceutical formulations. Additionally, her work on methods of use for fenofibric acid includes formulations described for immediate-release dosage forms, showcasing her expertise in developing versatile pharmaceutical solutions.
Career Highlights
Kristin has worked with Mutual Pharmaceutical Company, Inc., where she has contributed to numerous pioneering projects. Her experience encompasses various facets of pharmaceutical development, cementing her status as a leader in her field.
Collaborations
Throughout her career, Kristin has collaborated with esteemed colleagues such as Hengsheng Feng and Gandha V Naringrekar. These partnerships have fostered an innovative environment leading to enhanced research and development efforts in pharmaceutical sciences.
Conclusion
Kristin Anne Arnold’s work exemplifies the spirit of innovation and dedication in the realm of controlled-release formulations. Her contributions significantly impact the pharmaceutical industry, providing new methodologies for drug delivery and enhancing therapeutic outcomes. As an inventor, Kristin continues to inspire future generations in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile